Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

• 主要な著者: Kei Irie (著者), Atsushi Nakagawa (著者), Hirotoshi Fujita (著者), Ryo Tamura (著者), Masaaki Eto (著者), Hiroaki Ikesue (著者), Nobuyuki Muroi (著者), Keisuke Tomii (著者), Tohru Hashida (著者)
• フォーマット: 図書
• 出版事項: Wiley, 2020-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Since December 2019, a novel coronavirus (severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)) infection has been rapidly spreading worldwide and causing the respiratory illness, coronavirus disease 2019 (COVID‐19). The antiretroviral drug favipiravir (FPV) has been experimentally used for...